Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVelocity Comp Regulatory News (VEL)

Share Price Information for Velocity Comp (VEL)

Share Price is delayed by 15 minutes
Get Live Data
16.25    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.50 (3.125%)
Market Cap: £8.88m
VEL Live PriceLast checked at - London Stock Exchange

Intraday Velocity Comp Share Chart

Trading Statement

24 May 2021 07:00

RNS Number : 5115Z
Velocity Composites PLC
24 May 2021
 

24 May 2021

 

Velocity Composites plc

("Velocity" or the "Company")

 

Trading Update and Notice of Results

 

 

Velocity Composites plc (AIM: VEL), the leading supplier of advanced composite material kits to the aerospace sector, is pleased to provide the following trading update for the six months to 30 April 2021 ("H1 FY21").

 

The Board reported at the time of the FY20 full year results in January that having reduced the Company's operating cost-base following the adverse impact of the Covid 19 pandemic, Velocity is well placed to capitalise upon anticipated improving market conditions. In addition the new partner proposition from the Company has been well received by both existing and prospective new customers.

 

Since the start of the year the Company has made significant progress, with the announcements of three key contract extensions during H1 with three of the Company's largest customers, which represent in total an estimated annual value of over £8.1 million at current impacted build rates. This provides Velocity with a strong financial base for future growth. Whilst there has been a continuing reduction in near-term customer demand, as aerospace industry production is curtailed by COVID-19, progress made by the Company in the first half of 2021 provides the Board with a high level of confidence as to the long-term prospects of the business through continued efforts around prudent financial management and strategic re-alignment.

 

Trading update

 

As announced previously, demand in the current financial year ending 31 October 2021 ("FY21") remains suppressed due to the impact of Covid-19, although the Board now views with cautious optimism, prospects for an improved second half performance in FY21 and into FY22.

 

Although demand in the first six months has continued at the levels seen in H2 FY20, sales have stabilised and Management expect H1 FY21 sales of £4.4m (H1 FY20: £9.5m), leading to an adjusted EBITDA loss for H1 FY21 of £0.5m (H1 FY20: Loss £0.3m). With the organisational restructuring process completed, the Company's cost-base is now in line with a target £13.5m sales breakeven position and with further cost reduction activities Velocity is well placed to return to a positive adjusted EBITDA in H2 FY21 and FY22, albeit in challenging market conditions.

 

In addition to the aerospace contracts wins already announced this year, work has progressed in promoting Velocity technology in other composite material markets, particularly the defence sector. Due to restrictions on international travel these initiatives have been focused primarily in the UK and following a period of development with a large, multinational defence group the Company has recently achieved full approval to supply structural material kits for the F35 fighter, in addition to the process material kits already provided on this programme. Work is ongoing to establish a commercial position on this platform to support advancements in efficiency and digital manufacturing driven by Velocity's technology offering. The F35 approval will also assist negotiations with other suppliers into the same programme. These developments have further strengthened the Board's confidence of an improved trading position in the second half of the year.

 

Cash flow and liquidity remain satisfactory. The Company continues to drive cash flow efficiencies through improved stock management, reducing stock levels by over £1.1m since October 2020, and by the successful tenor extension of the existing £2.0m CBIL facility as previously announced. Cash at bank was £3.5m as at 30 April 2021 (30 April 2020: £2.8m) and the business remains in a net cash positive position, after deducting debt drawing. The Company continues to have access to its Invoice Discounting Facility, which was undrawn as at 30 April, but has current capacity of £1.6m based on outstanding receivables.

 

Notice of Results

 

The Company expects to announce its half year results for the six months ending 30 April 2021 on 30 June 2021.

 

Enquiries:

 

Velocity Composites plc

Andy Beaden, Chairman

Jon Bridges, Chief Executive Officer

Chris Williams, Finance Director

 

 

+44 (0)1282 577577

 

Cenkos Securities

(Nominated Adviser and Broker)

Russell Cook

Ben Jeynes

+44 (0)20 7397 8900

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDGGDUDSDDGBX
Date   Source Headline
26th May 20267:00 amRNSTrading Statement
6th May 20269:07 amRNSHolding(s) in Company
23rd Apr 20267:00 amRNSBoard Change
23rd Mar 20262:18 pmRNSGrant of Share Options to Directors/PDMRs
17th Mar 202611:11 amRNSResult of AGM
9th Feb 202612:15 pmRNSChange of Joint Broker
27th Jan 202612:42 pmRNSReplacement - Audited Final Results
27th Jan 20267:00 amRNSFinal Results to the 31 October 2025
13th Jan 20263:49 pmRNS-RNotice of Investor Presentation - Replacement
8th Jan 20267:00 amRNS-RNotice of Investor Presentation
27th Nov 202510:19 amRNSPDMR/Director shareholding
25th Nov 202511:18 amRNSGrant of Share Options to Directors/PDMRs
5th Nov 20257:00 amRNSTrading Update
8th Oct 20257:00 amRNSContract Renewal and Expansion
8th Jul 202510:43 amRNSExercise of Share Options and Issue of Equity
25th Jun 20257:00 amRNSUnaudited Half Year Results
29th May 20257:00 amRNS-RNotice of Investor Presentation
22nd May 20257:00 amRNSTrading Update & Notice of Results
14th May 20253:16 pmRNSExercise of Share Options and Issue of Equity
12th May 20257:00 amRNSRenewal of BAE Systems Contract
6th May 20254:53 pmRNSHolding(s) in Company
6th May 202510:41 amRNSHolding(s) in Company
29th Apr 20255:26 pmRNSExercise of Share Options and Issue of Equity
28th Apr 20254:37 pmRNSPublication of Annual Report and Accounts
28th Mar 20252:49 pmRNSExercise of Share Options and Issue of Equity
17th Mar 20251:51 pmRNSDirector/PDMR Shareholding
11th Mar 202512:15 pmRNSResult of AGM
5th Mar 202510:53 amRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNS-RAppointment of Chief Operations Officer
3rd Feb 20257:00 amRNSGrant of Share Options
29th Jan 20257:00 amRNSAudited Final Results to 31 October 2024
15th Jan 20257:00 amRNS-RNotice of Investor Presentation
24th Dec 20247:00 amRNSDirector/PDMR Shareholding
20th Dec 20243:26 pmRNSExercise of Share Options and Issue of Equity
12th Dec 20247:00 amRNSTrading Update & Notice of Results
4th Nov 20244:43 pmRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTotal Voting Rights
7th Oct 20247:00 amRNSDirector/PDMR Shareholding
26th Sep 20245:48 pmRNSExercise of Share Options and Issue of Equity
18th Sep 20247:00 amRNSTrading Update
17th Jul 202410:16 amRNSHolding(s) in Company
17th Jul 20247:00 amRNSGrant of Share Options
16th Jul 20247:00 amRNSDirector/PDMR Shareholding
9th Jul 20247:00 amRNSHalf-Year Results
22nd May 20247:00 amRNSTrading Update & Notice of Results
13th May 20245:12 pmRNSReplacement: Holding(s) in Company
13th May 20242:31 pmRNSHolding(s) in Company
2nd May 20247:00 amRNSChange of Nominated Adviser and Corporate Broker
8th Apr 20244:38 pmRNSDirector/PDMR Shareholding
8th Apr 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.